| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of OGT mRNA | CTD | PMID:22079256 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of OGT mRNA | CTD | PMID:16949557 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:62352 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to OGT promoter] | CTD | PMID:19654925 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:62352 | 6480464 | Tetrachlorodibenzodioxin affects the expression of OGT mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:62060 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OGT mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:62060 | 6480464 | Tetrachlorodibenzodioxin affects the expression of OGT mRNA | CTD | PMID:22298810 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:62060 | 6480464 | 2,6-dinitrotoluene affects the expression of OGT mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:62352 | 6480464 | Glucosamine results in decreased expression of OGT mRNA | CTD | PMID:17178593 |
| 8-bromo-3',5'-cyclic AMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of OGT mRNA | CTD | PMID:22079614 |
| aflatoxin B1 | increases expression | ISO | RGD:62352 | 6480464 | Aflatoxin B1 results in increased expression of OGT mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:62352 | 6480464 | Glucosamine results in decreased expression of OGT mRNA | CTD | PMID:17178593 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of OGT mRNA | CTD | PMID:15498508 |
| ammonium chloride | affects expression | ISO | RGD:62060 | 6480464 | Ammonium Chloride affects the expression of OGT mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | ISO | RGD:62352 | 6480464 | Benzo(a)pyrene results in increased expression of OGT mRNA | CTD | PMID:22228805 |
| beta-D-glucosamine | decreases expression | ISO | RGD:62352 | 6480464 | Glucosamine results in decreased expression of OGT mRNA | CTD | PMID:17178593 |
| C60 fullerene | affects expression | ISO | RGD:62060 | 6480464 | fullerene C60 affects the expression of OGT mRNA | CTD | PMID:19167457 |
| cadmium sulfate | decreases expression | EXP | | 6480464 | cadmium sulfate results in decreased expression of OGT mRNA | CTD | PMID:21783983 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin affects the reaction [Piroxicam results in decreased expression of OGT mRNA] | CTD | PMID:21858171 |
| cisplatin | increases phosphorylation | ISO | RGD:62352 | 6480464 | Cisplatin results in increased phosphorylation of OGT protein | CTD | PMID:22006019 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of OGT mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of OGT mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of OGT mRNA | CTD | PMID:20106945 |
| D-glucose | decreases expression | ISO | RGD:62352 | 6480464 | Glucose results in decreased expression of OGT mRNA | CTD | PMID:17178593 |
| diarsenic trioxide | increases response to substance | EXP | | 6480464 | OGT protein results in increased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| gamma-hexachlorocyclohexane | increases expression | ISO | RGD:62060 | 6480464 | Lindane results in increased expression of OGT mRNA | CTD | PMID:17785943 |
| glucose | decreases expression | ISO | RGD:62352 | 6480464 | Glucose results in decreased expression of OGT mRNA | CTD | PMID:17178593 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of OGT mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of OGT mRNA | CTD | PMID:20044591 |
| lamivudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of OGT mRNA | CTD | PMID:15784690 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of OGT mRNA | CTD | PMID:20044591 |
| methoxychlor | increases methylation | ISO | RGD:62060 | 6480464 | Methoxychlor results in increased methylation of OGT gene | CTD | PMID:23303685 |
| paracetamol | affects expression | ISO | RGD:62352 | 6480464 | Acetaminophen affects the expression of OGT mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of OGT mRNA | CTD | PMID:21420995 |
| phenobarbital | decreases expression | ISO | RGD:62352 | 6480464 | Phenobarbital results in decreased expression of OGT mRNA | CTD | PMID:19363144 |
| phenobarbital | increases expression | ISO | RGD:62352 | 6480464 | Phenobarbital results in increased expression of OGT mRNA | CTD | PMID:19270015 |
| pirinixic acid | decreases expression | ISO | RGD:62352 | 6480464 | pirinixic acid results in decreased expression of OGT mRNA | CTD | PMID:18445702 |
| pirinixic acid | decreases expression | ISO | RGD:62060 | 6480464 | pirinixic acid results in decreased expression of OGT mRNA | CTD | PMID:19162173 PMID:22484513 |
| pirinixic acid | decreases expression | ISO | RGD:62060 | 6480464 | pirinixic acid results in decreased expression of OGT mRNA | CTD | PMID:19162173 |
| piroxicam | multiple interactions | EXP | | 6480464 | Cisplatin affects the reaction [Piroxicam results in decreased expression of OGT mRNA] | CTD | PMID:21858171 |
| piroxicam | decreases expression | EXP | | 6480464 | Piroxicam results in decreased expression of OGT mRNA | CTD | PMID:21858171 |
| progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of OGT mRNA | CTD | PMID:18070364 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of OGT mRNA | CTD | PMID:18037150 |
| silicon dioxide | decreases expression | ISO | RGD:62352 | 6480464 | Silicon Dioxide results in decreased expression of OGT mRNA | CTD | PMID:19073995 |
| tamibarotene | decreases expression | EXP | | 6480464 | Am 80 results in decreased expression of OGT mRNA; more ... | CTD | PMID:15498508 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of OGT mRNA | CTD | PMID:15336504 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of OGT mRNA | CTD | PMID:17183730 |
| zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of OGT mRNA | CTD | PMID:15784690 |
| zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of OGT mRNA | CTD | PMID:12756304 |